Actively Recruiting
Validation of Proclarix Blood Test for Detecting Clinically Significant Prostate Cancer in a Multi-Ethnic US Population
Led by Sequenom, Inc. · Updated on 2026-09-28
500
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Prostate cancer is a common and serious disease that affects men worldwide, with black men often experiencing earlier, more frequent, and more aggressive forms. Current methods to assess and predict prostate cancer risk may not be precise enough for diverse populations. This study evaluates the performance of Proclarixae, a blood test designed to indicate the risk of clinically significant prostate cancer, in a diverse US population to confirm its accuracy beyond previous European validations. Proclarixae combines two new biomarkers, thrombospondin 1 and cathepsin D, with total and free prostate-specific antigen levels and age. Blood samples of up to 20 mL will be collected and tested using the Proclarixae assay. If recommended by the urologist, a prostate biopsy will be performed according to usual clinical practice, with a minimum of 10 cores if systematic biopsy is done. Biopsy results will be analyzed to detect clinically significant prostate cancer, defined as ISUP Grade Group 2 or higher. Participants will provide blood samples for testing and share diagnostic results during the study. Researchers will compare Proclarixae results with biopsy outcomes within 90 days, as well as assess its correlation with other standard diagnostic tests like MRI and ultrasound. The study aims to measure how well Proclarixae predicts clinically significant prostate cancer and its performance compared to other risk tools, with safety and data collected until biopsy results are obtained.
CONDITIONS
Brief Title
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Research Team
S
Senior Clinical Trial Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here